Clinical Trial Update: A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for anfibatide in acquired thrombotic thrombocytopenic purpura (TTP) is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Thrombotic Thrombocytopenic Purpura

Drugs mentioned

• Anfibatide (anfibatide)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Acquired Thrombotic Thrombocytopenic Purpura | Phase 2 | Status: UNKNOWN